Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial

Overview

About this study

The investigators will evaluate a technology-enabled strategy designed to promote medication adherence, routinely monitor regimen use, and mobilize appropriate transplant center resources to respond early to kidney transplant recipients demonstrating inadequate adherence.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age 18 or older
Within 3 months of KT (de novo) or 18-36 months post-KT (established)
English speaking
Primarily responsible for administering own medication
Own a cell phone and comfortable receiving text messages
Access and proficiency using internet in home.

Exclusion Criteria:

Any severe, uncorrectable vision, hearing or cognitive impairments

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Sumi Sukumaran Nair, M.B.B.S., M.D.	Closed for enrollment	Contact information: April Howard B.S.N., R.N. (480) 301-5756 Howard.April@mayo.edu

Mayo Clinic Location

Status

Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Sumi Sukumaran Nair, M.B.B.S., M.D.

Closed for enrollment

Contact information:

April Howard B.S.N., R.N.

(480) 301-5756

Howard.April@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials